Table 3.

Hematopoietic Recovery and Transfusion Support

ParameterPBSCPBSC/Split Group BGroup A v Group BCD34+ Group CCD34+/Split Group DGroup C v Group D P ValueComparison of all
Group A(n = 26)P Value3-152(n = 29)(n = 11)Four Groups
(n = 22)P Value
Days to AGC ≥500/μL 10  (8-11)3-150 8  (7-11) .0003 12 (8-22) 11 (9-13) .14 .0001 (C,D > A > B) 
Days to platelet independence 12  (8-24) 11.5 (5-21) .61 15 (6-22†) 14 (12-23) .85 .0007 (C,D > A,B) 
No. of RBC transfusions 4  (3-7) 4  (2-11) .84 6 (3-11) 4 (3-14) .45 .008 (C > A,B) 
No. of platelet transfusions 7.5 (3-33) 6  (2-52) .50 9 (2-26) 9 (6-22) .81 .33 
ParameterPBSCPBSC/Split Group BGroup A v Group BCD34+ Group CCD34+/Split Group DGroup C v Group D P ValueComparison of all
Group A(n = 26)P Value3-152(n = 29)(n = 11)Four Groups
(n = 22)P Value
Days to AGC ≥500/μL 10  (8-11)3-150 8  (7-11) .0003 12 (8-22) 11 (9-13) .14 .0001 (C,D > A > B) 
Days to platelet independence 12  (8-24) 11.5 (5-21) .61 15 (6-22†) 14 (12-23) .85 .0007 (C,D > A,B) 
No. of RBC transfusions 4  (3-7) 4  (2-11) .84 6 (3-11) 4 (3-14) .45 .008 (C > A,B) 
No. of platelet transfusions 7.5 (3-33) 6  (2-52) .50 9 (2-26) 9 (6-22) .81 .33 

Abbreviation: RBC, red blood cell.

F3-150

Median (range).

F3-151

One patient died before reaching platelet independence.

F3-152

P value derived from linear regression analysis applied to the ranks of data.

Close Modal

or Create an Account

Close Modal
Close Modal